Upcoming Meetings
SEPTEMBER 7-9
• European Cancer Summit: ECCO2018
Vienna, Austria
SEPTEMBER 14-16
• International Liver Cancer Association (ILCA) 12th Annual Conference
London, UK
SEPTEMBER 23-26
• International Association for the Study of Lung Cancer (IASLC) 19th World Conference on Lung Cancer
Toronto, ON
SEPTEMBER 28-29
• American Society of Clinical Oncology (ASCO) Quality Care Symposium
Phoenix, AZ
Recent Conference Coverage
Two Programs, One Goal: Meeting the Challenges of Oncology Navigation
An in-depth review of 2 navigation systems, presented at the 2018 ONA Navigation Summit, identified the challenges and solutions that can build effective, efficient programs that ensure patients have access to the care and resources they need to achieve their goals throughout their cancer journey.
Lung Cancer: What Nurse Navigators Need to Know in 2018
There have been many recent changes in lung cancer, including updated early detection possibilities and changes in diagnostic procedures, reporting, and treatment options. These are reviewed in a presentation at the 2018 ONA Navigation Summit.
Navigating Patients with Hematologic Malignancies
Patients with hematologic cancers often require a combination of inpatient and outpatient care. The oncology nurse navigator is an ideal care provider to help patients manage their care and transitions between care settings, according to a presentation at the 2018 ONA Navigation Summit.
Navigating the Benefits and Challenges of Immunotherapy
A review of immunotherapy — what they are, how they work, and what to watch for — was presented at the 2018 ONA Navigation Summit.
Difficult Conversations: The Role of Nurse Navigator
Suggestions for communication points that improve the experience of patients with cancer through nurse navigation were presented at the 2018 ONA Navigation Summit.
Navigating Patients With Gastrointestinal Cancer
The unique challenges that face both oncology nurse navigators specializing in gastrointestinal cancer and patients with these diseases are reviewed in a presentation at the 2018 ONA Navigation Summit.
Developing a Specialty Multidisciplinary Breast Clinic
Creating a multidisciplinary breast clinic can ensure that patients with breast cancer receive care that is timely, effective, and efficient, according to a presentation at the 2018 ONA Navigation Summit.
Navigating Patients With Head and Neck Cancer: Important Roles and Responsibilities of the Oncology Nurse Navigator
The head and neck oncology nurse navigator (ONN) is a unique and critical position to help patients, their families, and their caregivers as they face their diagnosis and undergo treatment.
Development of App Aimed at Improving Patient Navigation Services in Underserved Populations
The technology will facilitate data entry for patient navigation activities, evaluation of one or more patient navigators (PNs), and generate reports.
The Health Care Mortgage: Understanding the Complexities of Financial Toxicity
Cost of cancer care is more than co-pays for medications and treatment. Cancer can affect a patient's ability to work compounding the financial costs of their care, as described in this presentation at the 2018 ONA Navigation Summit.
Two Programs, One Goal: Meeting the Challenges of Oncology Navigation
An in-depth review of 2 navigation systems, presented at the 2018 ONA Navigation Summit, identified the challenges and solutions that can build effective, efficient programs that ensure patients have access to the care and resources they need to achieve their goals throughout their cancer journey.
Development of App Aimed at Improving Patient Navigation Services in Underserved Populations
The technology will facilitate data entry for patient navigation activities, evaluation of one or more patient navigators (PNs), and generate reports.
Patient Advocacy, Questioning 'Status Quo,' Improves Safety in Ambulatory Infusion Setting
In fielding reports of CNS-related adverse effects from patients in the ambulatory infusion room, nurses were able to prompt a pharmacy practice review. The outcomes of the resulting switch in premedication for HSR was presented at the 2018 ONS Annual Congress.
NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
A clinic staffed with clinical research nurses provided needed care for patients in clinical trials who experienced adverse effects, and also ensured consistent documentation of treatment-related AEs, according to a presentation at the 2018 ONS Annual Congress.
Oncology Evaluation Center May Improve Health and Cost Outcomes in Cancer
Researchers reported on their study that investigated the feasibility of operating a same-day clinic for urgent care for patients currently receiving cancer treatment. These results were presented at the 2018 ONS Annual Congress.
Clinical Research Nursing Staff an Important Part of Oncology Clinical Trial Programs
The importance of oncology clinical research nurses in the clinical trial process was explored in a study presented at the 2018 ONS Annual Congress.
Multimodal Follow-up Improved Postradiotherapy Sexual Health in Lower GI, Gynecologic Cancers
Researchers sought to determine the effectiveness of a multimodal continuity of care program for women receiving radiation therapy for gynecologic or lower GI cancers. Their findings were presented at the 2018 ONS Annual Congress.
Lung Cancer Screening Program In Ambulatory Clinics May Improve Detection Rates
A study presented at the 2018 ONS Annual Congress explored the feasibility of an advanced practice nurse-led lung cancer screening program at ambulatory outpatient clinics.
Nursing Practice Change Improved Chemo Administration, But Old Habits Die Hard
A nursing staff worked together to identify and work a solution to a high rate of "near-misses" in chemotherapy administration, but further evaluation and additional interventions are needed to maintain the successful practice change, study findings presented at 2018 ONS Annual Congress have shown.
Simple Adjustment Key to Paclitaxel Infusion Protocol That Reduced Hypersensitivity Reactions
A project presented at the 2018 ONS Annual Congress demonstrated the effectiveness of standardizing nursing practices for paclitaxel infusions.
A Retrospective Look at Drug Sensitivity Before and After Checkpoint Blockade in R/R NHL
Checkpoint-based therapies may sensitize patients to subsequent therapies.
Prior Bortezomib Lowers Incidence of Lenalidomide-Induced Skin Toxicity in Multiple Myeloma
A study presented at ESMO 2018 demonstrated that incidence of skin toxicity in patients with multiple myeloma undergoing lenalidomide therapy was lower in those who received prior bortezomib.
Nonadherence to Tamoxifen Higher Than Reported Among Premenopausal Patients With Breast Cancer
Assessment of a subgroup of a cohort study revealed that many patients undergoing tamoxifen therapy for early-stage breast cancer do not adhere to their prescribed treatment, even though they claim adherence on patient surveys.
Chemotherapy Side Effects in Women vs Men: Broader Range, More Severe
An analysis of pooled data from 4 randomized controlled clinical trials revealed that male and female patients experience different chemotherapy side effects and at different severities, according to a poster presented at ESMO 2018 Congress.
Routine Scanning in Early-Stage Breast Cancer Unnecessary, Greater Harms
A study presented at 2018 ASCO Quality Care Symposium demonstrates further support for Choosing Wisely Initiative's recommendations against routine scanning in early-stage breast cancer.
SCOOPs Program Improves Patient Experience, Reduces Costs
Researchers report on the effectiveness results of the Supportive Care of Oncology Patients (SCOOPs) Program were presented at the 2018 ASCO Quality Care Symposium.
Lung Cancer: What Nurse Navigators Need to Know in 2018
There have been many recent changes in lung cancer, including updated early detection possibilities and changes in diagnostic procedures, reporting, and treatment options. These are reviewed in a presentation at the 2018 ONA Navigation Summit.
Navigating Patients with Hematologic Malignancies
Patients with hematologic cancers often require a combination of inpatient and outpatient care. The oncology nurse navigator is an ideal care provider to help patients manage their care and transitions between care settings, according to a presentation at the 2018 ONA Navigation Summit.
Navigating the Benefits and Challenges of Immunotherapy
A review of immunotherapy — what they are, how they work, and what to watch for — was presented at the 2018 ONA Navigation Summit.
Difficult Conversations: The Role of Nurse Navigator
Suggestions for communication points that improve the experience of patients with cancer through nurse navigation were presented at the 2018 ONA Navigation Summit.
Sign Up for Free e-newsletters
ONA Articles
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- Takeda to Collaborate With MSKCC on CAR-T Therapies for Multiple Myeloma
- Sequential Immunotherapy, Targeted Therapy Linked to Cutaneous Adverse Events in Advanced Melanoma
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- NIH Establishes Educational Program on Genomics, Genetics for Oncology Nurses
- Oncology Nurse Navigation Facilitates Timely Treatment of Pancreatic Cancer
- Helping Patients Face the Challenge of Eating Healthy During Cancer Treatment
- Oncology Nurses Weigh In on Their Patient-Centered Communication Practices, Needs
- Substitute for Lidocaine
- CART cell therapy for prostate cancer: status and promise
- Immunotherapy for HER2-positive Breast Cancer: Recent Advances and Combination Therapeutic Approaches
- Survey Demonstrates Relationship Between Symptom Burden, Medical Disability Leave Among Myeloproliferative Neoplasms
- A Review of Clinical Outcomes in Patients With Early-Stage Burkitt Lymphoma
- FDA: Number of U.S. Women With Breast Implant-Caused Cancer Has Increased
- USPSTF Still Recommends Against Pancreatic Cancer Screening
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |